UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the month of December 2024

 

Commission File Number: 001-40614

 

INTERCURE LTD.

(Translation of registrant’s name into English)

 

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

 

 

 
 

 

On December 30, 2024, an Annual General Meeting of Shareholders of Intercure Ltd. (the “Company”) approved each of the five proposals brought before the Company’s shareholders at the meeting, in accordance with the majority required for each proposal. Each of those proposals was described in the Company’s Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders, dated November 25, 2024, attached as Exhibit 99.1 to the Company’s Form 6-K that was furnished to the U.S. Securities and Exchange Commission on November 25, 2024.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INTERCURE LTD.
   
Date: December 30, 2024 /s/ Amos Cohen
  Amos Cohen
  Chief Financial Officer

 

 

 

Intercure (NASDAQ:INCR)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Intercure Charts.
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Intercure Charts.